Detalhe da pesquisa
1.
Glofitamab as a salvage treatment for B-cell lymphomas in the real world: A multicenter study in Taiwan.
Cancer
; 130(11): 1972-1981, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306242
2.
Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.
Br J Cancer
; 128(7): 1294-1300, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717672
3.
Flow Cytometry Analysis Reveals a Wide Cytologic and Immunophenotypic Spectrum of Peripheral B Lymphocytes in Angioimmunoblastic T-Cell Lymphoma.
Pathobiology
; 90(3): 187-198, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423589
4.
Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR-Mutated MPN.
Int J Mol Sci
; 24(10)2023 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37240094
5.
Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia.
Cancer Sci
; 113(10): 3518-3527, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869805
6.
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(5): 678-689, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33848462
7.
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics.
Br J Haematol
; 194(1): 120-131, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34036560
8.
Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
Exp Mol Pathol
; 118: 104577, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242451
9.
The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma.
J Formos Med Assoc
; 120(11): 1967-1976, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33551311
10.
Molecular heterogeneity unravelled by single-cell transcriptomics in patients with essential thrombocythaemia.
Br J Haematol
; 188(5): 707-722, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610612
11.
RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
Exp Mol Pathol
; 110: 104294, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394087
12.
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan.
J Formos Med Assoc
; 116(9): 705-710, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28012677
13.
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial.
Haematologica
; 106(12): 3240-3244, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551506
14.
Characteristics of Taiwanese patients of PNH in the international PNH registry.
Thromb J
; 14(Suppl 1): 39, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27766064
15.
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.
Hepatology
; 59(6): 2092-100, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24002804
16.
Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Hematol Oncol
; 33(4): 136-44, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25111959
17.
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.
Lancet Oncol
; 15(11): 1195-206, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25242045
18.
TMPRSS6 rs855791 polymorphism influences the susceptibility to iron deficiency anemia in women at reproductive age.
Int J Med Sci
; 11(6): 614-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24782651
19.
Pooled Analysis of Pralatrexate Single-Agent Studies in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma.
Blood Adv
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429077
20.
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Haematol
; 11(1): e38-e50, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38065203